SLC9A3 and inflammatory bowel disease: Several studies have shown reduced NHE3 expression/activity in IBD patients and after exposure to proinflammatory cytokines and Clostridium difficile toxin B; however, it has been uncertain until recently whether the downregulation of NHE3 plays a causal role rather than simply reflecting the disease (116–118).